ViBrANT (VIral and BacteRial Adhesin Network Training) brings together an interdisciplinary team of world-leading European infection researchers, focused on a cutting-edge translational research project to understand host-pathogen...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
PRONTO
self-PoweRed cONductimeter for digiTalization of rapid mOlec...
150K€
Cerrado
Información proyecto ViBrANT
Duración del proyecto: 57 meses
Fecha Inicio: 2017-08-31
Fecha Fin: 2022-06-30
Líder del proyecto
UNIVERSITY OF LEEDS
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
ViBrANT (VIral and BacteRial Adhesin Network Training) brings together an interdisciplinary team of world-leading European infection researchers, focused on a cutting-edge translational research project to understand host-pathogen adhesion and to develop novel, highly-specific nanoscale diagnostics to improve patient care. Host-pathogen interactions are the basis for infectious diseases, but the research methodologies needed to unravel these interactions and translate them into viable diagnostic tools are complex and change rapidly.
ViBrANT will deliver high-impact fundamental and translational science and in so doing will educate 15 ESRs. We have the demonstrated track-record and infrastructure to train ESRs in highly innovative methodologies, including structural biology, proteomics, genetics, comparative genomics, lab-on-a-chip technology and the development of state of the art diagnostics in the field of infectious diseases. ViBrANT will investigate the poorly understood structure-function relationships between pathogen adhesins and hosts in an integrative manner. The ESRs in the project will have extensive intersectoral mobility across 7 EU/EEA countries, accessing the best complementary skills in each of the hosting institutions. ViBrANT comprises 8 leading universities, 1 public research institution and 6 companies (from SME to multinational). The project will impact adhesion biology in general; the detection of multi-antibiotic resistant human pathogens will have priority.
The ESRs will acquire the necessary skills to translate fundamental research into technologies that will have a strong positive effect on the care of patients with infectious diseases. ViBrANT science will be high-impact and deliver 15 highly-trained innovative researchers and a long-lasting inter-sectoral collaborative network. Together, we will continue to develop fundamental research and translate it for the socio-economic benefit of Europe.